Investor Presentation - First Six Months of 2021

94 Investor presentation First six months of 2021 Diabetes market share and market growth in EMEA EMEA Diabetes market growth and Novo Nordisk market share Diabetes market size and growth DKK ~4% 80% billion 90 2 1 0 93 93 60% 40% 20% 0% -20% May 2018 50% 28% 7% NN market share Market growth (right axis) NN share of growth -NN growth (right axis) Source: IQVIA, May 2021, Value, MAT; NN: Novo Nordisk; BI- Boehringer Ingelheim 4% 27.3% -7% 28.1% May May Novo Nordisk BI Others 2021 2020 May 2021 Novo Nordisk Competitors

View entire presentation